About
Glycans
Areas of Focus
Categories
Non-PharmaceuticalDrug Delivery & Formulation
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
9
As Collaborator
0
Total Enrollment
1,541
By Phase
PHASE2: 3PHASE1: 3PHASE1/PHASE2: 3
By Status
COMPLETED: 5ACTIVE_NOT_RECRUITING: 2RECRUITING: 2
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06523231Lead Sponsor
Study to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants.
PHASE2Active, not recruiting
110 participants
Started: Apr 7, 2025 · Completed: Feb 28, 2026
NCT06719219Lead Sponsor
A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus.
PHASE1Active, not recruiting
129 participants
Started: Jan 7, 2025 · Completed: May 31, 2026
NCT06615375Lead Sponsor
A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine
PHASE2Recruiting
120 participants
Started: Nov 12, 2024 · Completed: Jul 31, 2026
NCT06190509Lead Sponsor
Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study
PHASE1/PHASE2Recruiting
251 participants
Started: Dec 6, 2023 · Completed: Dec 31, 2026
NCT04959344Lead Sponsor
Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)
PHASE1/PHASE2Completed
166 participants
Started: Jul 5, 2021 · Completed: Sep 26, 2022
Locations (1)
Headquarters
Schlieren, Switzerland
Map
Loading map...